BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
2022 · Cell & Bioscience · 25 citations
https://doi.org/10.1186/s13578-022-00769-8
R
Ran Zhuo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
309
Citations
12
h-index
14
i10-index
Ran Zhuo is an academic researcher from Soochow University. The author has contributed to research in topics: Protein Degradation and Inhibitors & Ubiquitin and proteasome pathways & Neuroblastoma Research and Treatments. The author has an h-index of 12, co-authored 24 publications.
ORCID: 0000-0003-3180-643XPapers by this author
worksBRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia
2022 · Journal of Immunology Research · 17 citations
https://doi.org/10.1155/2022/7912484
SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7
2022 · Cell Death and Disease · 16 citations
https://doi.org/10.1038/s41419-022-04624-z
LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1
2023 · Cell Death and Disease · 13 citations
https://doi.org/10.1038/s41419-023-06039-w
CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma
2024 · Cancer Letters · 9 citations
https://doi.org/10.1016/j.canlet.2024.216882
The BET PROTAC inhibitor GNE-987 displays anti-tumor effects by targeting super-enhancers regulated gene in osteosarcoma
2024 · BMC Cancer · 7 citations
https://doi.org/10.1186/s12885-024-12691-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat